M.B. Khazaeli

5.5k citations

90 papers · 4.4k indexed · h-index 36

Radiology, Nuclear Medicine and Imaging top 0.5%
Molecular Biology top 5%
Oncology top 2%
Immunology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Albert F. LoBuglio Richard Wheeler Ruby F. Meredith Mansoor N. Saleh Robert M. Conry G. Yancey Gillespie John Ghrayeb William E. Grizzle
Topics: Monoclonal and Polyclonal Antibodies Research (40 papers)Radiopharmaceutical Chemistry and Applications (35 papers)Lymphoma Diagnosis and Treatment (13 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Chemical Health and Safety Oncology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Oncology The Journal of Immunology
Partner nations: United States Canada Germany

In The Last Decade

M.B. Khazaeli

87 papers receiving 4.2k citations

Peers

Countries citing papers authored by M.B. Khazaeli

Since Specialization

Citations

This map shows the geographic impact of M.B. Khazaeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.B. Khazaeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.B. Khazaeli more than expected).

Fields of papers citing papers by M.B. Khazaeli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.B. Khazaeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.B. Khazaeli. The network helps show where M.B. Khazaeli may publish in the future.

Co-authorship network of co-authors of M.B. Khazaeli

This figure shows the co-authorship network connecting the top 25 collaborators of M.B. Khazaeli. A scholar is included among the top collaborators of M.B. Khazaeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.B. Khazaeli. M.B. Khazaeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Testicular Uptake and Radiation Dose in Patients Receiving Zevalin ^™ and Pretarget ^™ CC49Fusion Protein 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Sui Shen,Ruby F. Meredith,Jun Duan,Andres Forero,Hazel B. Breitz,M.B. Khazaeli,I Brezovich,Albert F. LoBuglio	3
2	Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-72 Fusion Protein 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Andres Forero‐Torres,Sui Shen,Hazel B. Breitz,Robert B. Sims,Don B. Axworthy,M.B. Khazaeli,(unknown),Ivor Percent,(unknown),Albert F. LoBuglio	20
3	Pharmacokinetics and Clinical Evaluation of ¹²⁵ I-Radiolabeled Humanized CC49 Monoclonal Antibody (HuCC49ΔC _H 2) in Recurrent and Metastatic Colorectal Cancer Patients 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Jim Xiao,Sara N. Horst,George H. Hinkle,Xianhua Cao,Ergun Kocak,Jing‐Yuan Fang,Donn C. Young,M.B. Khazaeli,Doreen M. Agnese,Duxin Sun,Edward W. Martin	21
4	Intraperitoneal Radioimmunotherapy with a Humanized Anti-TAG-72 (CC49) Antibody with a Deleted CH2 Region 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Buck E. Rogers,Peter L. Roberson,Sui Shen,M.B. Khazaeli,Mark Carpenter,Shigeru Yokoyama,Martin W. Brechbiel,Albert F. LoBuglio,Donald J. Buchsbaum	19
5	Phase I Study of ⁹⁰ Y-CC49 Monoclonal Antibody Therapy in Patients with Advanced Non-Small Cell Lung Cancer: Effect of Chelating Agents and Paclitaxel Co-Administration 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Andres Forero,Ruby F. Meredith,M.B. Khazaeli,Sui Shen,William E. Grizzle,Delicia Carey,(unknown),Albert F. LoBuglio,Francisco Robert	19
6	A PHASE I/II CLINICAL TRIAL FOR ADULT RECURRENT GLIOMA USING 131I-TM-601, AN IODINATED PEPTIDE DERIVED FROM SCORPION VENOM 2004 ·Iranian journal of pharmaceutical research ·M.B. Khazaeli,Vernon L. Alvarez	2
7	A Novel Monoclonal Antibody Design for Radioimmunotherapy 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·Andres Forero,Ruby F. Meredith,M.B. Khazaeli,David M. Carpenter,Sui Shen,Jennifer Thornton,Jeffrey Schlom,Albert F. LoBuglio	22
8	Comparison of Biodistribution, Dosimetry, and Outcome from Clinical Trials of Radionuclide-CC49 Antibody Therapy 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·Ruby F. Meredith,Sui Shen,Daniel J. Macey,M.B. Khazaeli,Delicia Carey,Francisco Robert,Albert F. LoBuglio	13
9	Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma 2003 ·Human Pathology ·David C. Chhieng,Cristina Rodríguez-Burford,Lynya Talley,(unknown),Cecil R. Stockard,(unknown),Mack N. Barnes,Edward E. Partridge,M.B. Khazaeli,William E. Grizzle	24
10	Intraperitoneal Radioimmunochemotherapy of Ovarian Cancer: A Phase I Study 2001 ·Cancer Biotherapy and Radiopharmaceuticals ·Ruby F. Meredith,Ronald D. Alvarez,Edward E. Partridge,M.B. Khazaeli,Chin-Yu Lin,Daniel J. Macey,J.Maxwell Austin,Larry C. Kilgore,William E. Grizzle,Jeffrey Schlom,Albert F. LoBuglio	70
11	Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N′,N″,N‴-tris(acetic acid)cyclododecane (PA-DOTA) 1999 ·Bioorganic & Medicinal Chemistry ·Lara L. Chappell,Buck E. Rogers,M.B. Khazaeli,Matthew S. Mayo,Donald J. Buchsbaum,Martin W. Brechbiel	34
12	Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study 1997 ·Gynecologic Oncology ·Ronald D. Alvarez,Edward E. Partridge,M.B. Khazaeli,(unknown),M. E. Austin,Larry C. Kilgore,Charles D. Russell,Tiepu Liu,William E. Grizzle,Jeffrey Schlom,Albert F. LoBuglio,Ruby F. Meredith	144
13	Production of Mouse Monoclonal Anti-Idiotypic Antibodies Specific to Epitopes of Tumor-Associated Mucin TAG-12 1994 ·Hybridoma ·(unknown),M.B. Khazaeli,Cynthia M. Rodenburg,Sepp Kaul,G. Bastert	5
14	A new method of labeling monoclonal antibodies with indium-111 using DOTA-NHS as the chelating agent 1994 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Yang Zhou,M.B. Khazaeli,Donald J. Buchsbaum	0
15	90 Y-labeled 17-1A monoclonal antibody prepared using the new bifunctional chelating agent DOTA-NHS 1994 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Yang Zhou,M.B. Khazaeli,Donald J. Buchsbaum	0
16	Phase II Multicenter Evaluation of Prolonged Murine Monoclonal Antibody 17-1A Therapy in Pancreatic Carcinoma 1993 ·Journal of Immunotherapy ·Louis M. Weiner,Elizabeth Harvey,Kristin Padavic‐Shaller,James K. V. Willson,Christine M. Walsh,Frank LaCreta,M.B. Khazaeli,John M. Kirkwood,Daniel G. Haller	35
17	A Phase I Escalating-Dose Safety, Dosimetry and Efficacy Study of Radiolabeled Monoclonal Antibody LYM-1 1993 ·PubMed ·(unknown),(unknown),Aline Zimmer,Edward A. Silverstein,Stewart Spies,(unknown),(unknown),Martin Birkhofer,Dan Shochat,Albert F. LoBuglio,Ruby F. Meredith,M.B. Khazaeli,(unknown),Eddie Hu,David Chen,Kai Lee,Kristy Watkins	26
18	Pharmacokinetics of a Mouse/Human Chimeric Monoclonal Antibody (C-17-1 A) in Metastatic Adenocarcinoma Patients 1990 ·Pharmaceutical Research ·(unknown),Albert F. LoBuglio,Richard Wheeler,Elizabeth B. Harvey,Lee K. Sun,John Ghrayeb,M.B. Khazaeli	21
19	Radioimmunoassay of free ß-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease 1989 ·American Journal of Obstetrics and Gynecology ·M.B. Khazaeli,(unknown),Roland A. Pattillo,Seng‐Jaw Soong,Kenneth D. Hatch	22
20	Direct quantitation of IgG subclasses 1, 2, and 3 bound to red cells by Rh1 (D) antibodies 1988 ·Transfusion ·D R Shaw,Mary Ellen Conley,(unknown),M.B. Khazaeli,Albert F. LoBuglio	19

About M.B. Khazaeli

M.B. Khazaeli is a scholar working on Chemical Health and Safety, Radiology, Nuclear Medicine and Imaging and Reproductive Medicine, having authored 90 papers that have together received 4.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (40 papers), Radiopharmaceutical Chemistry and Applications (35 papers) and Lymphoma Diagnosis and Treatment (13 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.3k citations), Chemical Health and Safety (33 citations) and Oncology (1.4k citations). M.B. Khazaeli has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Albert F. LoBuglio, Richard Wheeler, Ruby F. Meredith, Mansoor N. Saleh, Robert M. Conry, G. Yancey Gillespie, John Ghrayeb, William E. Grizzle, Tiepu Liu and James A. Bonner. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact